The national registry of veterans with amyotrophic lateral sclerosis

被引:41
作者
Allen, K. D. [1 ,4 ]
Kasarskis, E. J.
Bedlack, R. S. [2 ,3 ,4 ]
Rozear, M. P. [2 ,3 ,4 ]
Morgenlander, J. C. [2 ,3 ,4 ]
Sabet, A. [6 ]
Sams, L.
Lindquist, J. H. [1 ]
Harrelson, M. L. [1 ]
Coffman, C. J. [1 ,5 ]
Oddone, E. Z. [1 ,4 ]
机构
[1] Duke Univ, Med Ctr, Epidemiol Res & Informat Ctr, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Neurol Serv, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Neurol Serv, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[5] Duke Univ, Dept Biostat & Biostat, Lexington, KY USA
[6] Gold Coast Hosp, Dept Neurosci, Southport, Qld, Australia
关键词
amyotrophic lateral sclerosis; veterans; registries; DNA data banks;
D O I
10.1159/000126910
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The Department of Veterans Affairs (VA) Cooperative Studies Program has established a National Registry of Veterans with Amyotrophic Lateral Sclerosis (ALS). This article describes the objectives, methods, and sample involved in the registry. Methods: United States military veterans with ALS were identified through national VA electronic medical record databases and nationwide publicity efforts for an enrollment period of 4 1/2 years. Diagnoses were confirmed by medical record reviews. Registrants were asked to participate in a DNA bank. Follow-up telephone interviews are conducted every 6 months to track participants' health status. Results: As of September 30, 2007, 2,400 veterans had consented to participate in the registry, 2,068 were included after medical record review, 995 were still living and actively participating, and 1,573 consented to participate in the DNA bank. 979 participants had been enrolled in the registry for at least 1 year, 497 for at least 2 years, and 205 for at least 3 years. Fourteen studies have been approved to use registry data for epidemiological, observational, and interventional protocols. Conclusion: This registry has proven to be a successful model for identifying large numbers of patients with a relatively rare disease and enrolling them into multiple studies, including genetic protocols. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:180 / 190
页数:11
相关论文
共 33 条
  • [1] [Anonymous], 1996, Arch Neurol, V53, P141
  • [2] Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150
  • [3] Braunwald E., 2001, Harrison's principles of internal medicine, V15th
  • [5] Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
  • [6] BROOKS BR, 2001, ALS OTHER MOTOR N S1, V1, pS19
  • [7] The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
    Cedarbaum, JM
    Stambler, N
    Malta, E
    Fuller, C
    Hilt, D
    Thurmond, B
    Nakanishi, A
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 169 (1-2) : 13 - 21
  • [8] Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7
    C. Cermelli
    M. Vinceti
    F. Beretti
    V. Pietrini
    G. Nacci
    P. Pietrosemoli
    A. Bartoletti
    D. Guidetti
    P. Sola
    M. Bergomi
    G. Vivoli
    M. Portolani
    [J]. European Journal of Epidemiology, 2003, 18 (2) : 123 - 127
  • [9] THE PROGNOSIS OF ADULT-ONSET MOTOR-NEURON DISEASE - A PROSPECTIVE-STUDY BASED ON THE SCOTTISH MOTOR-NEURON DISEASE REGISTER
    CHANCELLOR, AM
    SLATTERY, JM
    FRASER, H
    SWINGLER, RJ
    HOLLOWAY, SM
    WARLOW, CP
    [J]. JOURNAL OF NEUROLOGY, 1993, 240 (06) : 339 - 346
  • [10] Head injury and amyotrophic lateral sclerosis
    Chen, Honglei
    Richard, Marie
    Sandier, Dale P.
    Umbach, David M.
    Kamel, Freya
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (07) : 810 - 816